Inhibition of GSDMD Activates Poly(ADP‐ribosyl)ation and Promotes Myocardial Ischemia‐Reperfusion Injury
Open Access
- 1 January 2022
- journal article
- research article
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2022 (1) , 1115749
Abstract
The precise control of cardiomyocyte viability is imperative to combat myocardial ischemia‐reperfusion injury (I/R), in which apoptosis and pyroptosis putatively contribute to the process. Recent researches indicated that GSDMD is involved in I/R as an executive protein of pyroptosis. However, its effect on other forms of cell death is unclear. We identified that GSDMD and GSDMD‐N levels were significantly upregulated in the I/R myocardium of mice. Knockout of GSDMD conferred the resistance of the hearts to reperfusion injury in the acute phase of I/R but aggravated reperfusion injury in the chronic phase of I/R. Mechanistically, GSDMD deficiency induced the activation of PARylation and the consumption of NAD+ and ATP, leading to cardiomyocyte apoptosis. Moreover, PJ34, a putative PARP‐1 inhibitor, reduced the myocardial injury caused by GSDMD deficiency. Our results reveal a novel action modality of GSDMD in the regulation of cardiomyocyte death; inhibition of GSDMD activates PARylation, suggesting the multidirectional role of GSDMD in I/R and providing a new theory for clinical treatment.Keywords
Funding Information
- National Natural Science Foundation of China (82070291, 81870183, 82170266)
This publication has 43 references indexed in Scilit:
- Poly(ADP-ribose) signaling in cell deathMolecular Aspects of Medicine, 2013
- ROS‐Mediated PARP Activity Undermines Mitochondrial Function After Permeability Transition Pore Opening During Myocardial Ischemia–ReperfusionJournal of the American Heart Association, 2013
- Pretreatment of therapeutic cells with poly(ADP-ribose) polymerase inhibitor enhances their efficacy in an in vitro model of cell-based therapy in myocardial infarctInternational Journal of Molecular Medicine, 2012
- The PARP inhibitor PJ34 causes a PARP1-independent, p21 dependent mitotic arrestDNA Repair, 2011
- Myocardial Matrix Remodeling and the Matrix Metalloproteinases: Influence on Cardiac Form and FunctionPhysiological Reviews, 2007
- Protective effects of the PARP-1 inhibitor PJ34 in hypoxic-reoxygenated cardiomyoblastsCellular and Molecular Life Sciences, 2006
- Poly Adenosine Diphosphate-Ribose Polymerase Inhibitor PJ34 Abolishes Systemic Proinflammatory Responses to Thoracic Aortic Ischemia and ReperfusionJournal of the American College of Surgeons, 2006
- Acute myocardial infarction and heart failure: Role of apoptosisThe International Journal of Biochemistry & Cell Biology, 2006
- Poly(ADP-ribose) polymerase-1 mediated caspase-independent cell death after ischemia/reperfusionFree Radical Biology and Medicine, 2005
- Pathophysiologic role of myocardial apoptosis in post‐infarction left ventricular remodelingJournal of Cellular Physiology, 2002